Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers-Tentative...
Registration Country : India
Brand Name :
Dosage Form : Powder for Solution fo...
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers-Tentative...
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers-Tentative...
Registration Country : India
Brand Name :
Dosage Form : Powder for Solution fo...
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers-Tentative...
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentativ...
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentativ...
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentativ...
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentativ...
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentativ...
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1G/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentativ...
Registration Country : India
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Alvopem
Dosage Form : Vial
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Alvopem
Dosage Form : Vial
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
66
PharmaCompass offers a list of Pemetrexed API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pemetrexed manufacturer or Pemetrexed supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pemetrexed manufacturer or Pemetrexed supplier.
PharmaCompass also assists you with knowing the Pemetrexed API Price utilized in the formulation of products. Pemetrexed API Price is not always fixed or binding as the Pemetrexed Price is obtained through a variety of data sources. The Pemetrexed Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ALIMTA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ALIMTA, including repackagers and relabelers. The FDA regulates ALIMTA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ALIMTA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of ALIMTA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A ALIMTA supplier is an individual or a company that provides ALIMTA active pharmaceutical ingredient (API) or ALIMTA finished formulations upon request. The ALIMTA suppliers may include ALIMTA API manufacturers, exporters, distributors and traders.
click here to find a list of ALIMTA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A ALIMTA DMF (Drug Master File) is a document detailing the whole manufacturing process of ALIMTA active pharmaceutical ingredient (API) in detail. Different forms of ALIMTA DMFs exist exist since differing nations have different regulations, such as ALIMTA USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A ALIMTA DMF submitted to regulatory agencies in the US is known as a USDMF. ALIMTA USDMF includes data on ALIMTA's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The ALIMTA USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of ALIMTA suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing ALIMTA as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for ALIMTA API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture ALIMTA as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain ALIMTA and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a ALIMTA NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of ALIMTA suppliers with NDC on PharmaCompass.
ALIMTA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ALIMTA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ALIMTA GMP manufacturer or ALIMTA GMP API supplier for your needs.
A ALIMTA CoA (Certificate of Analysis) is a formal document that attests to ALIMTA's compliance with ALIMTA specifications and serves as a tool for batch-level quality control.
ALIMTA CoA mostly includes findings from lab analyses of a specific batch. For each ALIMTA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ALIMTA may be tested according to a variety of international standards, such as European Pharmacopoeia (ALIMTA EP), ALIMTA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ALIMTA USP).
